Literature DB >> 6425898

Involvement of dopamine in the antinociceptive response to footshock.

M D Tricklebank, P H Hutson, G Curzon.   

Abstract

The effects of drugs which alter dopaminergic function on footshock-induced antinociception were studied in the rat. Antinociception due to brief (30 s) footshock was inversely related to dopamine (DA). Thus, it was increased by the DA receptor antagonists pimozide and haloperidol and decreased by the specific D2 dopamine receptor agonist LY 141865, but not by the specific D1 agonist SKF 38393. Although pimozide increased the antinociceptive effect of 30-s shock, it decreased that of 30-min shock. It is suggested that DA may have physiological roles in stress-induced antinociception, and that these may differ according to the duration of stress.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6425898     DOI: 10.1007/bf00427770

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

1.  Decrease in morphine's analgesic action and increase in its cataleptic action by 6-hydroxydopamine injected bilaterally into caudate and putamen areas; partial restoration by L-DOPA plus decarboxylase inhibition.

Authors:  K Nakamura; R Kuntzman; A Maggio; A H Conney
Journal:  Neuropharmacology       Date:  1973-12       Impact factor: 5.250

2.  The role of neurotransmitters in stress-induced antinociception (SIA).

Authors:  A E Snow; S M Tucker; W L Dewey
Journal:  Pharmacol Biochem Behav       Date:  1982-01       Impact factor: 3.533

3.  Antagonistic effects of psycholeptic drugs on stress-induced analgesia.

Authors:  T Doi; N Sawa
Journal:  Arch Int Pharmacodyn Ther       Date:  1980-10

4.  Evidence for the potentiation of the antinociceptive action of morphine by bromocriptine.

Authors:  J Robertson; R Weston; M J Lewis; S Barasi
Journal:  Neuropharmacology       Date:  1981-11       Impact factor: 5.250

5.  Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor.

Authors:  K Tsuruta; E A Frey; C W Grewe; T E Cote; R L Eskay; J W Kebabian
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

6.  Effect of apomorphine on the antinociceptive activity of morphine.

Authors:  Z Dunai-Kovács; J I Székely
Journal:  Psychopharmacology (Berl)       Date:  1977-06-06       Impact factor: 4.530

7.  Analgesia induced by brief footshock is inhibited by 5-hydroxytryptamine but unaffected by antagonists of 5-hydroxytryptamine or by naloxone.

Authors:  M D Tricklebank; P H Hutson; G Curzon
Journal:  Neuropharmacology       Date:  1982-01       Impact factor: 5.250

8.  Analgesia induced by brief or more prolonged stress differs in its dependency on naloxone, 5-hydroxytryptamine and previous testing of analgesia.

Authors:  M D Tricklebank; P H Hutson; G Curzon
Journal:  Neuropharmacology       Date:  1984-04       Impact factor: 5.250

9.  Analgesia induced by brief footshock: blockade by fenfluramine and 5-methoxy-N,N-dimethyltryptamine and prevention of blockade by 5-HT antagonists.

Authors:  P H Hutson; M D Tricklebank; G Curzon
Journal:  Brain Res       Date:  1983-11-21       Impact factor: 3.252

10.  The central effects of a novel dopamine agonist.

Authors:  P E Setler; H M Sarau; C L Zirkle; H L Saunders
Journal:  Eur J Pharmacol       Date:  1978-08-15       Impact factor: 4.432

View more
  3 in total

1.  Dissociated effects of apomorphine on various nociceptive responses in mice.

Authors:  F Gonzales-Rios; A Vlaiculescu; L Ben Natan; P Protais; J Costentin
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

2.  Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception.

Authors:  A R Burkey; E Carstens; L Jasmin
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

3.  Free-operant avoidance behavior by rats after reinforcer revaluation using opioid agonists and D-amphetamine.

Authors:  Anushka Fernando; Gonzalo Urcelay; Adam Mar; Anthony Dickinson; Trevor Robbins
Journal:  J Neurosci       Date:  2014-04-30       Impact factor: 6.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.